18 09, 2024

Analysts Think Oracle Stock Can Keep Climbing Higher, But is it Really a Good Time to Buy ORCL?

By |2024-09-18T19:03:23+00:00September 18th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , |

Shares of Oracle (ORCL) have climbed more than 57% through 2024 thus far, and they’re up more than 20% in the past month alone. The stock has been on a tear, but investors think it still has plenty of room to go. The recent 5-day rally showed 22% growth, making it the stock’s best [...]

17 09, 2024

What Tupperware’s Bankruptcy Announcement Means for Investors

By |2024-09-17T18:25:40+00:00September 17th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , |

Tupperware Brands (TUP) lost almost all of its value overnight after the company announced it would be filing for bankruptcy. The stock sat at $1.19 per share but has plummeted 57% to just $0.5 per share this morning. Exchanges like Robinhood have halted trading on the stock since. It’s been a tumultuous stretch for [...]

16 09, 2024

Intel Gets $3.5 Billion Grant From US Department of Defense, But Still Time to Sell INTC – Here’s Why…

By |2024-09-17T15:46:27+00:00September 16th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , , , , |

Shares of Intel Corporation (INTC) are up nearly 4% through Monday morning so far after news broke of the company’s $3.5 billion grant awarded under the “Secure Enclave” program by the US Department of Defense. These funds will be used to produce advanced semiconductors which will then be used for our country’s strategic defense [...]

13 09, 2024

Adobe’s Weak Guidance Overshadows Strong Q3 Results: 3 Other Things Investors Need to Consider

By |2024-09-17T15:46:31+00:00September 13th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , |

Adobe Inc. (ADBE) reported third-quarter earnings yesterday after the market closed, and while earnings and revenue both came in above the analyst consensus, the focus remained on lackluster guidance for the current quarter. Here’s how the company performed in Q3: Adjusted earnings per share: $4.65 compared to the $4.53 consensus. Revenue: $5.41 billion compared [...]

12 09, 2024

Lovesac Stock Jumps 25% on Q2 Earnings Results, But Is This Reason Enough to BUY LOVE?

By |2024-09-17T15:46:35+00:00September 12th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , |

Lovesac Co. (LOVE) has gained more than 24% so far Thursday morning after delivering a somewhat mixed bag for the second quarter of fiscal 2025. The company saw sales climb, yet profits shrunk.  Still, the company managed to beat the analyst expectations on both the top and bottom lines for Q2. The loss of [...]

11 09, 2024

The Presidential Debate is Affecting Trump’s Media Company: 3 Things DJT Investors Need to See

By |2024-10-21T16:46:24+00:00September 11th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , |

The debate America has long been anticipating took place last night between former president Donald Trump and current Vice President Kamala Harris.  The general consensus as of Wednesday morning is that Trump put on a somewhat rocky performance, with many believing Harris performed better than expected. Even conservative voters aren’t thrilled with what they [...]

10 09, 2024

What the EU’s Court Verdict Means for Apple: Plus, 3 Other Things for AAPL Investors to Consider

By |2024-10-21T16:46:32+00:00September 10th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , |

It was a bad day for tech companies in the European Union (EU) court system as both Apple (AAPL) and Google (GOOGL) lost their battles and will face hefty financial penalties as a result. Apple was fighting a €13 billion ($14.4 billion) Irish tax bill, which can be traced all the way back to [...]

6 09, 2024

Vaxcyte Trial Results Suggest it Could Compete With Pfizer: Is it Worth Buying This Stock Today?

By |2024-09-06T17:12:21+00:00September 6th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , |

Earlier this week Vaxcyte (PCVX) shared an update on its VAX-31 trial results, which are quite promising. The stock popped nearly 50% on the news, sending shares to an all-time high of $115/share.  VAX-31 is the company’s pneumococcal conjugate vaccine. This disease can contribute to more serious illnesses such as pneumonia, meningitis, and various [...]

18 07, 2024

Dominos Drops 12% on Weak Revenue, Decreased Store Openings: Is it Time to Sell DPZ?

By |2024-07-18T19:58:42+00:00July 18th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , , , |

Domino’s Pizza inc. (DPZ) reported second-quarter earnings early Thursday morning. While the company’s profits surpassed analyst expectations, the focus was on a disappointing revenue miss. As a result, the stock is down more than 12% so far today. Here are the results: EPS: $4.03 per share compared to the $3.68 consensus Revenue: $1.098 billion [...]

17 07, 2024

ASML’s Q2 Earnings and Sales Beat the Estimate, But the Stock is Down 10%: Should You Sell?

By |2024-07-17T17:19:38+00:00July 17th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , , , , , , |

ASML (ASML) reported second-quarter earnings that surpassed Wall Street’s expectations on both the top and bottom lines and yet, the market responded by sending shares 10% lower. The Dutch semiconductor manufacturer saw a surge in demand for the quarter, beating its original forecast and culminating in the following results: Sales: $6.79 billion vs $6.53 [...]

Go to Top